378 related articles for article (PubMed ID: 20627694)
21. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
Ammar AS; Mahmoud KM; Kasemy ZA
Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
[TBL] [Abstract][Full Text] [Related]
22. Reversal of profound neuromuscular blockade with sugammadex after failure of rapid sequence endotracheal intubation: a case report.
Barbosa FT; da Cunha RM
Rev Bras Anestesiol; 2012; 62(2):281-4. PubMed ID: 22440384
[TBL] [Abstract][Full Text] [Related]
23. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
24. Sugammadex: another milestone in clinical neuromuscular pharmacology.
Naguib M
Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
[TBL] [Abstract][Full Text] [Related]
25. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
[TBL] [Abstract][Full Text] [Related]
26. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
27. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia.
Williamson RM; Mallaiah S; Barclay P
Acta Anaesthesiol Scand; 2011 Jul; 55(6):694-9. PubMed ID: 21480829
[TBL] [Abstract][Full Text] [Related]
28. [Sugammadex, a novel drug for neuromuscular blockade reversal].
Fernández Meré LA; Alvarez-Blanco M
Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
[TBL] [Abstract][Full Text] [Related]
29. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
[TBL] [Abstract][Full Text] [Related]
30. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
[TBL] [Abstract][Full Text] [Related]
31. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
[TBL] [Abstract][Full Text] [Related]
32. [Use of sugammadex in patients undergoing caesarean section using general anesthesia with rocuronium].
Shibusawa M; Ejima Y; Nishino R; Toyama H; Kurosawa S
Masui; 2012 Aug; 61(8):805-9. PubMed ID: 22991799
[TBL] [Abstract][Full Text] [Related]
33. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
Ren WH; Jahr JS
Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
[TBL] [Abstract][Full Text] [Related]
34. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
Meistelman C; Donati F
Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
[TBL] [Abstract][Full Text] [Related]
35. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
Cammu G; Coart D; De Graeve K; Beelen R
Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
[TBL] [Abstract][Full Text] [Related]
36. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
37. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
[TBL] [Abstract][Full Text] [Related]
38. Preclinical pharmacology of sugammadex.
Bom A; Hope F; Rutherford S; Thomson K
J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
[TBL] [Abstract][Full Text] [Related]
39. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
[TBL] [Abstract][Full Text] [Related]
40. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
